0001179110-19-007007.txt : 20190603 0001179110-19-007007.hdr.sgml : 20190603 20190603164702 ACCESSION NUMBER: 0001179110-19-007007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190530 FILED AS OF DATE: 20190603 DATE AS OF CHANGE: 20190603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MINOGUE MICHAEL R CENTRAL INDEX KEY: 0001286370 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 19873862 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DR STREET 2: C/O ABIOMED INC CITY: DANVERS STATE: MA ZIP: 01923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 4 1 edgar.xml FORM 4 - X0306 4 2019-05-30 0 0000815094 ABIOMED INC ABMD 0001286370 MINOGUE MICHAEL R C/O ABIOMED, INC., 22 CHERRY HILL DRIVE DANVERS MA 01923 1 1 0 0 Chairman, President, CEO Common Stock $.01 par value 2018-08-09 4 G 0 64018 0 D 318890 D Common Stock $.01 par value 2019-05-29 4 G 0 29850 0 D 289040 D Common Stock $.01 par value 2018-08-09 4 G 0 64018 0 A 110672 I By Trust - A Common Stock $.01 par value 2018-11-20 4 G 0 23810 0 D 86862 I By Trust - A Common Stock $.01 par value 2018-11-21 4 G 0 85040 0 D 1822 I By Trust - A Common Stock $.01 par value 2019-05-29 4 G 0 29850 0 A 31672 I By Trust - A Common Stock $.01 par value 73745 I By Trust - B Common Stock $.01 par value 9000 I By Trust - C Common Stock $.01 par value 2018-11-20 4 G 0 23810 0 A 32810 I By Trust - C Common Stock $.01 par value 655 I By Trust - D Common Stock $.01 par value 38560 I By Trust - E Common Stock $.01 par value 2018-11-21 4 G 0 85040 0 A 85040 I By Trust - F Stock Option (Right to Buy) 22.44 2013-05-22 2022-05-22 Common Stock 0 100000 D Stock Option (Right to Buy) 23.15 2014-05-14 2023-05-14 Common stock 0 85000 D Stock Option (right to buy) 21.55 2015-05-14 2024-05-14 Common Stock 0 85000 D Stock Option (right to buy) 66.25 2016-05-13 2025-05-13 Common Stock 0 35000 D Stock Option (right to buy) 99.62 2017-05-24 2026-05-24 Common Stock 0 30500 D Stock Option (right to buy) 134.51 2018-05-15 2027-05-15 Common Stock 0 33000 D Stock Option (right to buy) 381.97 2019-05-16 2028-05-16 Common Stock 0 30000 D Stock Option (right to buy) 266.39 2019-05-30 4 A 0 50000 0 A 2020-05-30 2029-05-30 Common Stock 50000 50000 D These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan. This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse in a trustee of the trust. This transaction represents the transfer of common stock by bona fide gift from a trust held for the benefit of reporting person's spouse to a trust held for a foundation account This transaction represents the transfer of common stock by bona fide gift from a trust held for the benefit of reporting person's spouse to a trust /s/ Ian W. McLeod (by power of attorney) 2019-06-03 EX-24 2 ex24minogue.txt LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Stephen McEvoy, Ian McLeod, Michael Dube and Linda Day, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 2nd day of October, 2008 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ Michael R. Minogue Print Name: Michael R. Minogue